Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene.

NOG-8 ras cells are a normal mouse mammary epithelial cell line transfected with a plasmid containing a glucocorticoid-inducible mouse mammary tumor virus long terminal repeat linked to the activated c-Ha-ras protooncogene. After addition of dexamethasone, there is a rapid induction (within 1-3 h) of p21ras protein that is concomitant with a parallel induction of the c-Ha-ras specific mRNA. After 4-6 days of dexamethasone treatment, NOG-8 ras cells are able to grow as colonies in semisolid medium. Between 9 and 12 days of dexamethasone treatment, there is a 5- to 6-fold increase of transforming growth factor alpha (TGF alpha) activity in the conditioned medium from NOG-8 ras cells. A 60-65% reduction in epidermal growth factor cell surface receptors on NOG-8 ras cells also occurs during this time interval. A 3- to 4-fold increase of the expression of a specific TGF alpha mRNA can be detected within 2 days of dexamethasone treatment, preceding the increase in TGF alpha protein found in the conditioned medium. Exogenous TGF alpha is able to stimulate in a dose-dependent fashion the anchorage-dependent and anchorage-independent growth of NOG-8 ras cells to a level comparable to that observed in dexamethasone treated ras-transformed NOG-8 ras cells. These results suggest that the enhanced expression of TGF alpha after induction of an activated ras protooncogene may be necessary for the anchorage-independent growth and subsequent morphological changes and the enhanced growth rate observed in ras-transformed mammary epithelial cells.

[1]  S. Bates,et al.  Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. , 1988, Molecular endocrinology.

[2]  T. Kurokawa,et al.  Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA , 1988, Molecular and cellular biology.

[3]  R. Weinberg,et al.  Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.

[4]  Y. Cho‐Chung,et al.  Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. , 1987, Cancer research.

[5]  R. Derynck,et al.  Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production. , 1987, Molecular endocrinology.

[6]  J. Rheinwald,et al.  Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed. , 1987, Oncogene research.

[7]  L M Wakefield,et al.  Distribution and modulation of the cellular receptor for transforming growth factor-beta , 1987, The Journal of cell biology.

[8]  Michael C. Ostrowski,et al.  Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells , 1987, Molecular and cellular biology.

[9]  J. Yokota,et al.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  A. Quaroni,et al.  Activated H-ras transforms rat intestinal epithelial cells with expression of α-TGF☆ , 1987 .

[11]  D. Twardzik,et al.  Expression and characterization of transforming growth factor alpha precursor protein in transfected mammalian cells , 1987, Molecular and cellular biology.

[12]  M. Sporn,et al.  Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Derynck,et al.  Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha‐transforming growth factors in ras‐transformed mouse mammary epithelial cells , 1987, Journal of cellular physiology.

[14]  R. Derynck,et al.  Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor , 1987, Cell.

[15]  E. Gelmann,et al.  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Weinberg,et al.  Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. , 1987, Science.

[17]  P. Hand,et al.  ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[18]  B. Groner,et al.  The v‐mos and H‐ras oncogene expression represses glucocorticoid hormone‐dependent transcription from the mouse mammary tumor virus LTR. , 1986, The EMBO journal.

[19]  C. Marshall,et al.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor , 1986, Molecular and cellular biology.

[20]  J. Schlom,et al.  Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. , 1986, Cancer research.

[21]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[22]  M. Sporn,et al.  Transforming growth factor-beta: biological function and chemical structure. , 1986, Science.

[23]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[24]  S. Bates,et al.  Characterization of estrogen responsive transforming activity in human breast cancer cell lines. , 1986, Cancer research.

[25]  R. Ladda,et al.  Protein kinase C and non-functional EGF receptor in K-ras transformed cells. , 1986, Biochemical and biophysical research communications.

[26]  M. Sporn,et al.  Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor , 1986, Molecular and cellular biology.

[27]  H. Moses,et al.  Growth factors and cancer. , 1986, Cancer research.

[28]  B. Weissman,et al.  Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program , 1985, Molecular and cellular biology.

[29]  M. Barbacid,et al.  ras gene Amplification and malignant transformation , 1985, Molecular and cellular biology.

[30]  A. Schreiber,et al.  A synthetic fragment of rat transforming growth factor alpha with receptor binding and antigenic properties. , 1985, Biochemical and biophysical research communications.

[31]  M. Stampfer,et al.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Abou-Issa,et al.  Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodents. , 1985, Biochemical and biophysical research communications.

[33]  B. Groner,et al.  New acceptor cell for transfected genomic DNA: oncogene transfer into a mouse mammary epithelial cell line , 1985, Molecular and cellular biology.

[34]  D. Salomon,et al.  Flat revertants derived from kirsten murine sarcoma virus‐transformed cells produce transforming growth factors , 1984, Journal of cellular physiology.

[35]  M. Sporn,et al.  Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. , 1984, The Journal of biological chemistry.

[36]  D. Salomon,et al.  Presence of transforming growth factors in human breast cancer cells. , 1984, Cancer research.

[37]  E. Chen,et al.  Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.

[38]  D. Spandidos,et al.  Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. , 1984, Anticancer research.

[39]  E. S. Kimball,et al.  Epidermal growth factor (EGF) binding to membranes immobilized in microtiter wells and estimation of EGF-related transforming growth factor activity. , 1984, Biochimica et biophysica acta.

[40]  E. Scolnick,et al.  Epidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Theilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus , 1983, Journal of virology.

[41]  H. Varmus,et al.  Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Kohn,et al.  Anchorage-independent growth-conferring factor production by rat mammary tumor cells. , 1982, Cancer research.

[43]  M. Sporn,et al.  Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. , 1982, Cancer research.

[44]  M. Barbacid,et al.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes , 1982, Nature.

[45]  E. Scolnick,et al.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family , 1982, Journal of virology.

[46]  C. Der,et al.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Weinberg,et al.  Isolation of a transforming sequence from a human bladder carcinoma cell line , 1982, Cell.

[48]  G. Hager,et al.  Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus , 1981, Cell.

[49]  S. Aaronson,et al.  Molecular cloning of integrated simian sarcoma virus: genome organization of infectious DNA clones. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Smith,et al.  Epithelial cell cultures from normal glandular tissue of mice. , 1974, Journal of the National Cancer Institute.

[51]  R. Derynck,et al.  Transforming growth factor α , 1988, Cell.

[52]  D. Salomon,et al.  Basic Science Review: Growth Factors in Cancer and Their Relationship to Oncogenes , 1986 .

[53]  Lowy Dr,et al.  The ras gene family. , 1986 .

[54]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[55]  M. Sporn,et al.  Increased secretion of type beta transforming growth factor accompanies viral transformation of cells , 1985, Molecular and cellular biology.

[56]  P. Linsley,et al.  Detection of larger polypeptides structurally and functionally related to type I transforming growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Stephenson,et al.  Transforming Growth Factors Produced by Viral-Transformed and Human Tumor Cells , 1984 .